Develops, manufactures, acquires and markets dermatology-focused specialty pharmaceutical products
PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to physicians and patients that demonstrably improve the skin. The company operates in two key segments: Onset Dermatologics, which focuses on prescription therapies, and PrecisionMD, which focuses on physician dispensed products. The company’s high quality dermatology product portfolio includes Locoid®, Hylatopic®, Clindagel®, Celfix DNA® and Relastin®, among others. PreCision continues to rapidly expand through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities. The company is based in Cumberland, Rhode Island and has approximately 175 employees.
- In 2010 Essex Woodlands led the founding equity investment, and led a subsequent round of capital for an add-on acquisition, to help establish PreCision Dermatology as a leading specialty pharmaceutical company and standalone dermatology platform.
- In February 2014, the company entered into an agreement to be sold to Valeant Pharmaceuticals for $475 million in cash, plus an additional $25 million payable upon the achievement of specific milestones.